Dry Eye Syndromes: all 1,325 studies
Page 12 of 14. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.
- Changes in Tear Osmolarity Over Time With Sustained Use of TheraTearsCompletedNCT02100787Not applicable
- Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye SyndromeCompletedNCT02092207Phase 2
- Safety and Efficacy of PG101 for Dry Eye SyndromeCompletedNCT02078661Phase 1/2
- Estrogen and the Outer Eye in Women During Fertility TreatmentStatus unknownNCT02072122
- Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)CompletedNCT02051023Phase 3
- Ocular Surface Immune Response in Dry Eye DiseaseCompletedNCT02042820
- Effects of Sustained Reading on the Ocular SurfaceTerminatedNCT02031172
- A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®WithdrawnNCT02028312Phase 4
- A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)CompletedNCT02014922Phase 4
- A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren SyndromeCompletedNCT02011776
- A Study To Investigate The Effects Of A Low Humidity Environment And Visual Tasking On Tear Film Protein CompositionCompletedNCT02005874
- Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseaseCompletedNCT02004067Phase 4
- Phase 3 Study of EBI-005 in Dry Eye DiseaseCompletedNCT01998802Phase 3
- Validating the Diagnostic Accuracy of Mediview 2.0 Software as an Image Analysis Tool of Meibomian GlandsCompletedNCT01991132Not applicable
- Dry Eye Symptoms and Quality of LifeCompletedNCT01988597
- Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy SubjectsCompletedNCT01970917Phase 4
- A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry EyeCompletedNCT01960010Phase 3
- Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry EyeCompletedNCT01959854Not applicable
- Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye PatientsWithdrawnNCT01957670Not applicable
- Investigation on Medical Management of Dry Eye PatientsCompletedNCT01942226
- Reproducibility of Anterior Segment Optical Coherence Tomography (AS-OCT) for Imaging ConjunctivochalasisCompletedNCT01933178Not applicable
- Reproducibility of LipiView Ocular Surface Interferometer (LipiView) for Measuring Tear Lipid Layer ThicknessCompletedNCT01933165Not applicable
- Effect of Contact Lens With Alginic Acid in Dry Eye PatientsCompletedNCT01918410Not applicable
- Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye SyndromeWithdrawnNCT01917539Not applicable
- A Late Phase II Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01890941Phase 2
- Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)Status unknownNCT01880463Not applicable
- Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye SyndromeCompletedNCT01864330Phase 4
- Treatment of Dry Eye Using 0.03% Tacrolimus Eye DropsCompletedNCT01850979Phase 4
- A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry EyeCompletedNCT01843894Phase 1/2
- A Pilot Study on the Use of a Sensory Panel to Assess Comfort Between Three Different Contact LensesCompletedNCT01840787Not applicable
- Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye SyndromesCompletedNCT01804361Phase 3
- A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry EyeWithdrawnNCT01791426Not applicable
- Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular PainCompletedNCT01776658Phase 1/2
- Systane Ultra Versus Maxidex Versus SalineCompletedNCT01775540Not applicable
- Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension GroupCompletedNCT01768312Phase 3
- Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple InstillationCompletedNCT01753752Phase 2
- Correlation of Different Signs for Assessment of Dry Eye SyndromeCompletedNCT01753687Not applicable
- Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye DiseaseWithdrawnNCT01753596Phase 3
- Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult SubjectsCompletedNCT01748578Phase 1
- Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact LensesCompletedNCT01747616Phase 1
- A Multi-Center Study Subjects With Dry Eye SyndromeCompletedNCT01745887Phase 1
- Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy SubjectsCompletedNCT01744457Not applicable
- Efficacy and Safety of a Treatment for Dry Eye Syndrome: ThealozCompletedNCT01742884Phase 4
- A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye DiseaseCompletedNCT01733992Phase 1
- Evaluation of Corneal Epithelial Thickness MappingCompletedNCT01712022
- A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01692145Phase 2
- Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic SolutionCompletedNCT01684852
- Evaluating Patients With Eye Allergies and Determining if There Are Also Dry EyesCompletedNCT01679015
- A Study of RX-10045 in the Treatment of Dry Eye DiseaseCompletedNCT01675570Phase 2
- Phase II Study of DA-6034 Eye Drops in Dry Eye SyndromeCompletedNCT01670357Phase 2
- Efficacy and Safety of Rebamipide in Subjects With Dry Eye SyndromeCompletedNCT01632137Phase 3
- The Effect of Electrical Stimulation on Tear ProductionCompletedNCT01630291Not applicable
- Optimization of Assessment and Grading for Lid Wiper EpitheliopathyCompletedNCT01611922
- Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's SyndromeCompletedNCT01601028Phase 3
- Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane BalanceStatus unknownNCT01589640
- The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated OphthalmopathyCompletedNCT01579539Phase 3
- Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye DiseaseCompletedNCT01562795Not applicable
- Oral Nutrition Impact on Tear FilmStatus unknownNCT01561040Phase 4
- A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry EyeCompletedNCT01558999Phase 2
- Effect of Controlled Adverse Environment (CAE) on Tear Film StabilityCompletedNCT01547936
- Efficacy Study of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye ComplaintsCompletedNCT01543061Phase 4
- The Effect of Hinge Location on Corneal Sensation and Dry Eye After LASIK: A Systematic Review and Meta-analysisCompletedNCT01507025
- Comparison of Evaporimetry With the Established Methods of Tear Film MeasurementCompletedNCT01496482
- Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry EyeCompletedNCT01488396Phase 4
- In Vivo Measurement of Corneal Epithelial Changes in Dry Eye PatientsCompletedNCT01483989Not applicable
- Repeatability and Agreement of Anterior Segment Optical Coherence Tomography (AS-OCT) and ThermographyCompletedNCT01479790Not applicable
- A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye DiseaseWithdrawnNCT01478555Phase 2
- Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)CompletedNCT01476332Phase 1
- Analysis of Cataract Surgery Induced Dry EyeCompletedNCT01471561
- A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye PatientsCompletedNCT01468168Phase 2
- Corneal Sensation and Incidence of Dry Eye Post Refractive Cataract Extraction With FemtoSecond LaserStatus unknownNCT01441895
- Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy VolunteersCompletedNCT01438281Phase 1
- Safety Evaluation of a New Preservative in a Lubricating Eye DropCompletedNCT01434277Not applicable
- A Phase II Study of KCT-0809 in Patients With Dry Eye SyndromeCompletedNCT01427816Phase 2
- Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up TimeWithdrawnNCT01417013Not applicable
- Moisture Chamber Glasses for Dry Eye in Asian PopulationCompletedNCT01388426Not applicable
- Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of OsmolarityStatus unknownNCT01386073Phase 4
- Efficacy of the Chronic Application of Tear FormulationsStatus unknownNCT01384851Not applicable
- Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and SymptomsStatus unknownNCT01382810Phase 4
- Objective Evaluation of Ocular Surface Lubricants in Two EnvironmentsCompletedNCT01375582Early Phase 1
- Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular EmulsionCompletedNCT01368198Not applicable
- Treatment of Dry Eye With SupplementsWithdrawnNCT01364311Not applicable
- Sodium Hyaluronate and Wavefront Aberrations in Dry EyesCompletedNCT01363414Not applicable
- Comparison of Tolerability and Clinical Performance of Two Emulsion-type Artificial TearsStatus unknownNCT01335126Phase 3
- Diurnal Variation in Tear OsmolarityCompletedNCT01321424
- A Multi-Site Post Marketing Surveillance Study for Systane in Indian PatientsCompletedNCT01311609Phase 4
- A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)CompletedNCT01294956Not applicable
- Local Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young VolunteersCompletedNCT01278784Phase 1
- The Effect of Ocular Lubricant Eyedrops on Lid Parallel Conjunctival Folds and Other Signs and Symptoms of Dry EyeCompletedNCT01268735Phase 4
- Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry EyeCompletedNCT01257607Phase 2
- The Pathogenesis of Idiopathic Dry EyesCompletedNCT01254201
- Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and SalineCompletedNCT01252121Not applicable
- Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye DiseaseCompletedNCT01239069Phase 2
- Tear Osmolarity Over Time With Artificial TearsStatus unknownNCT01227226Phase 4
- A Study Of Tasocitinib In Dry Eye SubjectsWithdrawnNCT01226680Phase 2
- An Open-Label, Single-Center Study Evaluating the Effect of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in Patients Diagnosed With Dry EyeCompletedNCT01223040Not applicable
- Omega-3 Fatty Acid Supplements and Dry EyeTerminatedNCT01213342Not applicable
- A Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01211951Phase 2
- Diurnal Variation of Tear Meniscus and Tear OsmolarityCompletedNCT01206244
- Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis PatientsCompletedNCT01203540Phase 4